Patent: 8,455,439
✉ Email this page to a colleague
Summary for Patent: 8,455,439
Title: | Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents |
Abstract: | The present invention relates to antidotes of anticoagulants targeting factor Xa which antidotes are used in combination with blood coagulating agents or other heparin antidotes to prevent or reduce bleeding in a subject. The antidotes described herein have reduced or no intrinsic coagulant activity. Disclosed herein are methods of stopping or preventing bleeding in a patient that is or will be undergoing anticoagulant therapy with a factor Xa inhibitor. |
Inventor(s): | Lu; Genmin (Burlingame, CA), Sinha; Uma (San Francisco, CA) |
Assignee: | Portola Pharmaceuticals, Inc. (South San Francisco, CA) |
Application Number: | 12/616,735 |
Patent Claims: | see list of patent claims |
Details for Patent 8,455,439
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bayer Healthcare Pharmaceuticals Inc. | TRASYLOL | aprotinin | Injection | 020304 | 12/29/1993 | ⤷ Try a Trial | 2028-11-14 |
Baxalta Us Inc. | AUTOPLEX, FEIBA NF, FEIBA VH | anti-inhibitor coagulant complex | For Injection | 101447 | 12/21/1979 | ⤷ Try a Trial | 2028-11-14 |
Baxalta Us Inc. | AUTOPLEX, FEIBA NF, FEIBA VH | anti-inhibitor coagulant complex | For Injection | 101447 | 07/31/2000 | ⤷ Try a Trial | 2028-11-14 |
Baxalta Us Inc. | AUTOPLEX, FEIBA NF, FEIBA VH | anti-inhibitor coagulant complex | For Injection | 101447 | 08/11/2005 | ⤷ Try a Trial | 2028-11-14 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |